標(biāo)題: Titlebook: Contraception for the Medically Challenging Patient; Rebecca H. Allen,Carrie A. Cwiak Book 2014 Springer Science+Business Media New York 2 [打印本頁(yè)] 作者: 粗略 時(shí)間: 2025-3-21 18:43
書目名稱Contraception for the Medically Challenging Patient影響因子(影響力)
書目名稱Contraception for the Medically Challenging Patient影響因子(影響力)學(xué)科排名
書目名稱Contraception for the Medically Challenging Patient網(wǎng)絡(luò)公開度
書目名稱Contraception for the Medically Challenging Patient網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Contraception for the Medically Challenging Patient被引頻次
書目名稱Contraception for the Medically Challenging Patient被引頻次學(xué)科排名
書目名稱Contraception for the Medically Challenging Patient年度引用
書目名稱Contraception for the Medically Challenging Patient年度引用學(xué)科排名
書目名稱Contraception for the Medically Challenging Patient讀者反饋
書目名稱Contraception for the Medically Challenging Patient讀者反饋學(xué)科排名
作者: 斜 時(shí)間: 2025-3-21 21:37
Vorsorgendes Hochwassermanagement im Wandel with cardiac disease. Due to the increased risks associated with pregnancy for women with many cardiac conditions and the general safety of long-acting reversible contraception for most of these conditions, providers should consider these methods as a first line for women with cardiac disease.作者: agenda 時(shí)間: 2025-3-22 00:24
https://doi.org/10.1007/978-3-531-92304-8ion using these methods, data show an increased risk of both stroke and myocardial infarction, compared to women without hypertension. For these reasons, all women should have their blood pressure measured prior to initiation of estrogen-containing contraceptives. These methods are graded as categor作者: Benign 時(shí)間: 2025-3-22 07:36 作者: BUOY 時(shí)間: 2025-3-22 12:03 作者: Irrigate 時(shí)間: 2025-3-22 14:48
https://doi.org/10.1007/978-3-531-92357-4(IUD) or depot medroxyprogesterone acetate (DMPA, 150 mg). Recommendations for women taking no AED or non-inducing AEDs mirror those for their healthy peers. Estrogenic components of combined methods rapidly lead to large reductions in lamotrigine (LTG) levels. When combined hormonal methods are use作者: Irrigate 時(shí)間: 2025-3-22 19:18
https://doi.org/10.1007/978-3-531-92366-6tion of increased side effects or weight gain. This chapter reviews data on the efficacy, pharmacokinetics, and safety of modern methods of contraception in obese women, and in women undergoing bariatric surgery. We also address the effect of these contraceptive methods on lipid profiles.作者: 仇恨 時(shí)間: 2025-3-23 01:02 作者: 出血 時(shí)間: 2025-3-23 02:58 作者: Mortar 時(shí)間: 2025-3-23 08:39
Von der Kollegialit?t zur Hierarchie?increased risk for thrombosis due to the presence of antiphospholipid antibodies, the benefits of contraception outweigh the risks for most women with SLE. All contraceptive methods appear safe for most women with RA, with the exception of use of progestin-only injectables in women with the greatest作者: Afflict 時(shí)間: 2025-3-23 13:01 作者: vibrant 時(shí)間: 2025-3-23 16:53
Contraceptive Management of Women with Cardiac Disease, with cardiac disease. Due to the increased risks associated with pregnancy for women with many cardiac conditions and the general safety of long-acting reversible contraception for most of these conditions, providers should consider these methods as a first line for women with cardiac disease.作者: 推測(cè) 時(shí)間: 2025-3-23 18:51
Contraception Use in Women with Hypertension,ion using these methods, data show an increased risk of both stroke and myocardial infarction, compared to women without hypertension. For these reasons, all women should have their blood pressure measured prior to initiation of estrogen-containing contraceptives. These methods are graded as categor作者: 鎮(zhèn)痛劑 時(shí)間: 2025-3-24 00:03 作者: aspersion 時(shí)間: 2025-3-24 05:29
Contraception for Women with Mental Health Conditions,hical issues for reproductive autonomy and contraceptive decision-making for women with mental health conditions. Throughout, we note important gaps in scientific knowledge and areas for future research on mental health and contraception. Our goal is to offer a reference for health providers who car作者: inspiration 時(shí)間: 2025-3-24 09:25 作者: vertebrate 時(shí)間: 2025-3-24 13:52
Contraception in the Setting of Obesity and Bariatric Surgery,tion of increased side effects or weight gain. This chapter reviews data on the efficacy, pharmacokinetics, and safety of modern methods of contraception in obese women, and in women undergoing bariatric surgery. We also address the effect of these contraceptive methods on lipid profiles.作者: superfluous 時(shí)間: 2025-3-24 17:10
Contraceptive Options for Women with Thrombophilia and Thromboembolic Disease,for a current or a past VTE can safely use several effective contraceptive methods, including long-acting reversible contraception (LARC). Given the low typical-use failure rates of LARC methods, presenting such methods as first-line contraceptive agents should be routine in this population, as it s作者: 摘要記錄 時(shí)間: 2025-3-24 22:14
Contraception for Women with Endocrine Abnormalities, the effect of unopposed estrogen on the endometrium, androgenic symptoms, or obesity and insulin resistance. Overall, the benefits of contraceptive use outweigh the risks in most patients, but some women with PCOS and metabolic syndrome may have risk factors that should be considered prior to initi作者: BUDGE 時(shí)間: 2025-3-25 01:42 作者: Agility 時(shí)間: 2025-3-25 03:19 作者: 半球 時(shí)間: 2025-3-25 10:11 作者: 支柱 時(shí)間: 2025-3-25 13:05
Book 2014eds of today‘s medically challenging patients with HIV/AIDS, uterine fibroids or cardiac, neurologic?or thyroid disease. The book gives attention to recommendations on the use of contraception in women with medical problems such as diabetes, obesity, epilepsy, and lupus, among others and provides co作者: 表示問(wèn) 時(shí)間: 2025-3-25 19:48
neurologic?or thyroid disease. The book gives attention to recommendations on the use of contraception in women with medical problems such as diabetes, obesity, epilepsy, and lupus, among others and provides co978-1-4939-1232-2978-1-4939-1233-9作者: A精確的 時(shí)間: 2025-3-25 23:50
https://doi.org/10.1007/978-3-531-92357-4veral antiretroviral drugs may interact with hormonal contraceptives to reduce effectiveness, careful patient counseling during method selection and encouragement of dual protection with condoms are important.作者: Audiometry 時(shí)間: 2025-3-26 01:05
Hans-Joachim Lauth,Jürgen Winklerplant population, but modern literature is overwhelmingly reassuring. These studies, though small series, are largely reassuring. Long-acting reversible contraception (LARC) methods are underutilized in this population.作者: Generalize 時(shí)間: 2025-3-26 06:42 作者: 他一致 時(shí)間: 2025-3-26 11:31 作者: 吹氣 時(shí)間: 2025-3-26 16:20 作者: 抗原 時(shí)間: 2025-3-26 17:28
Contraception for Women Living with HIV,veral antiretroviral drugs may interact with hormonal contraceptives to reduce effectiveness, careful patient counseling during method selection and encouragement of dual protection with condoms are important.作者: 商談 時(shí)間: 2025-3-26 23:24
Contraception for Women with a History of Solid Organ Transplantation,plant population, but modern literature is overwhelmingly reassuring. These studies, though small series, are largely reassuring. Long-acting reversible contraception (LARC) methods are underutilized in this population.作者: delusion 時(shí)間: 2025-3-27 03:08
Contraception for Women with Hematologic Abnormalities,t of improved bleeding profiles and hematologic parameters. Sterilization is often appropriate for women who do not desire future fertility. Hysteroscopic sterilization minimizes blood loss and anesthesia risks, which are important considerations for women with hematologic abnormalities.作者: 大洪水 時(shí)間: 2025-3-27 08:40 作者: BUDGE 時(shí)間: 2025-3-27 11:05
Contraception in the Perimenopause,luding intrauterine devices, sterilization, combined hormonal contraceptives, implants, progestin-only contraceptives, and barrier methods. The effectiveness, risk, and contraindications of these methods can be different in perimenopausal women compared to younger women.作者: otic-capsule 時(shí)間: 2025-3-27 17:34 作者: 不確定 時(shí)間: 2025-3-27 20:54
d gastrointestinal disorders, as well as psychological and n.Women with chronic medical problems are at higher risk for complications during pregnancy and therefore, they are especially in need of appropriate preconception and contraception care. Furthermore, many women with chronic medical problems作者: Colonnade 時(shí)間: 2025-3-27 22:57
https://doi.org/10.1007/978-3-531-92357-4based approach is used to allow practitioners an understanding of how to implement best practice recommendations, especially the selection of appropriate candidates for initiation of hormone-containing contraceptives, and decision-making about method continuation among women complaining of headache while taking hormonal contraceptives.作者: Mets552 時(shí)間: 2025-3-28 02:41
https://doi.org/10.1007/978-3-531-92372-7ing several common disorders seen by women’s health care providers. In doing so, it is our goal that this text may serve as a reference for clinicians faced with gynecologic treatment dilemmas. As is appropriate in all medical fields, the use of contraceptives for gynecologic conditions should be as evidence based as possible.作者: esthetician 時(shí)間: 2025-3-28 09:01
Befunde der qualitativen Inhaltsanalyse,arkers of fertility, contraception is paramount to reduce the risk of an unintended pregnancy. Cancer survivors are less likely to be offered effective contraception, if offered at all. Models of conceptualizing contraception are outlined as well as strategies to implement oncocontraception within oncologic care.作者: 袖章 時(shí)間: 2025-3-28 13:27
https://doi.org/10.1007/978-3-531-92538-7of lactation will be considered in this discussion. Most of the chapter focuses on the impact of hormonal contraceptive use on bone health in healthy women and adolescents. In addition, consideration will also be given to the use of hormonal contraception in women at elevated risk for impaired bone health.作者: 不感興趣 時(shí)間: 2025-3-28 16:42 作者: Fsh238 時(shí)間: 2025-3-28 19:49 作者: Watemelon 時(shí)間: 2025-3-28 23:17 作者: 陳腐思想 時(shí)間: 2025-3-29 03:37 作者: 和平主義 時(shí)間: 2025-3-29 07:19 作者: coalition 時(shí)間: 2025-3-29 12:20 作者: 個(gè)人長(zhǎng)篇演說(shuō) 時(shí)間: 2025-3-29 17:02
Rebecca H. Allen,Carrie A. CwiakOffers advice on how to meet the contraceptive needs of women with chronic medical problems such as endocrine, rheumatologic, gynecologic and gastrointestinal disorders, as well as psychological and n作者: CALL 時(shí)間: 2025-3-29 19:59 作者: Atheroma 時(shí)間: 2025-3-30 00:04
Vorsorgender Umgang mit Hochwasser,sease on the pregnancy state. Appropriate contraceptive assessment, counseling, and management for these women are critical aspects of their medical care. Clinicians seeking guidance on contraceptive care may turn to the US Medical Eligibility Criteria (MEC), which are evidence-based guidelines crea作者: CRACK 時(shí)間: 2025-3-30 04:15 作者: Ornament 時(shí)間: 2025-3-30 09:26 作者: Countermand 時(shí)間: 2025-3-30 13:54 作者: 補(bǔ)充 時(shí)間: 2025-3-30 17:25 作者: Ordnance 時(shí)間: 2025-3-31 00:14 作者: 察覺 時(shí)間: 2025-3-31 01:45 作者: 報(bào)復(fù) 時(shí)間: 2025-3-31 05:36 作者: accrete 時(shí)間: 2025-3-31 09:23 作者: 間接 時(shí)間: 2025-3-31 14:23
https://doi.org/10.1007/978-3-531-92366-6 it has become a public health necessity to address the use and safety of contraception in obese women. Current research on contraceptive efficacy and safety in obese women is overall reassuring, and most contraceptives are given a category 1 rating (no restriction) for obesity by major regulatory a作者: 沉著 時(shí)間: 2025-3-31 21:02 作者: dapper 時(shí)間: 2025-4-1 00:24 作者: 前兆 時(shí)間: 2025-4-1 03:09
https://doi.org/10.1007/978-3-531-92372-7rtant to understand the data supporting the use of contraception for such indications. In some cases, research investigations have demonstrated clear benefits for using certain contraceptives for various gynecologic conditions. In others, only limited published research exists to guide treatment opt作者: synovitis 時(shí)間: 2025-4-1 07:18
Befunde der qualitativen Inhaltsanalyse,provements in treatments and prognosis, quality of life factors are increasing in importance for these women. Reproductive health is an important quality of life indicator. Focus on oncofertility has overshadowed other aspects of reproductive health including sexuality and oncocontraception. In this
